Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
April 17, 2014
Emergent BioSolutions to Participate in May 2014 Investor Conferences
...
Read More
April 16, 2014
Emergent BioSolutions Successfully Completes Pivotal Clinical Study to Support Expanded Indication for BioThrax
...
Read More
March 6, 2014
Emergent BioSolutions Reports Financial Results for 2013
...
Read More
March 3, 2014
Emergent BioSolutions to Release Fourth Quarter and Full Year 2013 Financial Results and Conduct a Conference Call on March 6, 2014
...
Read More
February 21, 2014
Emergent BioSolutions Completes Acquisition of Cangene Corporation
...
Read More
February 3, 2014
Emergent BioSolutions to Webcast Presentations at February and March 2014 Investor Conferences
...
Read More
January 29, 2014
Emergent BioSolutions Announces Completion of $250 Million Convertible Senior Notes Offering
...
Read More
January 28, 2014
Emergent BioSolutions Announces Expiration of the Hart-Scott-Rodino Waiting Period for Emergent’s Acquisition of Cangene Corporation
...
Read More
January 27, 2014
Emergent BioSolutions Announces $35 Million Option Exercised by the Initial Purchasers of the Company’s Convertible Senior Notes
...
Read More
January 24, 2014
Emergent BioSolutions Announces Pricing of Offering of $215 Million of 2.875% Convertible Senior Notes
...
Read More
January 22, 2014
Emergent BioSolutions Announces Proposed Offering of $200 Million Convertible Senior Notes
...
Read More
January 13, 2014
Emergent BioSolutions Announces Preliminary 2013 Financial Results and Provides 2014 Forecast
...
Read More
1
2
…
33
34
35
…
58
59
